Easy & Painless, Onsite, Surveillance Screening for SARS-CoV-2, the virus that causes COVID-19.
Safer Working Together ™
Safer Working Together ™
Get back to life with SARS-CoV-2 surveillance screening. Allow your organization to get back to activities in safety. Contact us and find out what screening plan is right for your organization.
SARS-CoV-2, the virus that causes COVID-19, continues to threaten the health of workers and their places of work. Businesses, desperate to keep their operations going, their staff and customers safe, are relying on ineffective surveys and unreliable thermometer checks to screen for possible infected individuals before they enter the workplace. However, did you know almost half of all SARS-CoV-2 infections will not result in symptoms detectable by these screening techniques?
Easy! We use a self-administered oral fluid collection system that comes with clear instructions for use. Sample collection is from the mouth and is easy, gentle, and safe.
This service is ideal for organizations with many staff and stakeholders where physical distancing is a challenge but downtime is not an option. Ensure your staff, personal support workers, school, students, co-workers, production crew, warehouse, logistics team, restaurant staff, or customers stay safe with SARS-CoV-2 surveillance screening.
We offer molecular surveillance of SARS-CoV-2 at the workplace. Our technology detects SARS-CoV-2 at the molecular level and does not rely on ineffective self reporting symptoms or unreliable temperature checks that can be evaded using common over-the-counter medications.
No! We use an oral swab. It is easy, gentle, non-invasive and not painful.
All results will have a 24-36 hour turnaround.
Frequency is your friend in mitigating risk. The shorter the interval between tests, the better for your organization.
We are set up for high volume and can do about 50,000 samples per day.
Fill in the form and an advisor to help you figure out the best program for your organization.
No. As per Public Health guidelines, we recommend continuing to use standard precautions, like masks and distancing when appropriate, to limit risk between screening intervals.
No. SARS-CoV-2 surveillance screening is not provided for the diagnosis, prevention, or treatment of disease. Results indicate risk of SARS-CoV-2 exposure. At-risk individuals should be isolated until a definitive diagnosis can be attained.
Yes, the CDC, FDA, Health Canada and Provincial Public Health authorities have proposed Pool Testing as a solution for SARS-CoV-2 surveillance testing.